3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
9
Lymphoma, Non-Hodgkin
7
Recurrence
2
Lymphoma
2
Cytokine Release Syndrome
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Solid Tumors
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Glioblastoma
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Craniopharyngioma
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Burkitt Lymphoma
1
Astrocytoma
1
Advanced Liver Cancers
1
Interventions
Rituximab
27
acalabrutinib
15
ibrutinib
13
Cyclophosphamide
12
Lenalidomide
10
CT-P10
10
zanubrutinib
9
venetoclax
9
Magnetic Resonance Spectroscopy
8
obinutuzumab
7
Specimen Handling
7
Cytarabine
7
Bendamustine Hydrochloride
7
pirtobrutinib
6
fludarabine
6
Biopsy
6
glofitamab
5
fludarabine phosphate
5
Peripheral Blood Stem Cell Transplantation
5
Cyclosporine
5
brexucabtagene autoleucel
4
Whole-Body Irradiation
4
Mycophenolic Acid
4
Vincristine
3
Stem Cell Transplantation
3
Sirolimus
3
Methotrexate
3
Etoposide
3
Doxorubicin
3
Cyclosporins
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Mantle-Cell
×
tocilizumab
×
90 days
×
Clear all
No trials found.